Dr. T.M. Luider

Update Persondata

• blood
• cancer
• cells
• children
• drug
• drugs
• expression
• gene
• immune
• lung
• patients
• peptide
• plasma
• tumor

Active as

Publications

(the most recent at the top)

Analytical investigations of toxic p-phenylenediamine (PPD) levels in clinical urine samples with special focus on MALDI-MS/MS

Fusion of metabolomics and proteomics data for biomarkers discovery: Case study on the experimental autoimmune encephalomyelitis

Dried blood spot UHPLC-MS/MS analysis of oseltamivir and oseltamivircarboxylate-a validated assay for the clinic

Label-free peptide profiling of Orbitrap™ full mass spectra

A new ultrafast and high-throughput mass spectrometric approach for the therapeutic drug monitoring of the multi-targeted anti-folate pemetrexed in plasma from lung cancer patients

All publications..

Current research

(the most recent research is at the top)
Project leader	Biomarkers for Cervical Cancer: From Discovery to the Clinic

Completed research projects

(the most recent research is at the top)
Project leader	The CSF proteome / metabolome as primary biomarker compartment for CNS disorders
Researcher	Biomarker Discovery Cervical Cancer
Researcher	Proteomics based biomarkers for clinical research
Project leader	Evaluation of l-caldesmon as biomarker for brain tumor monitoring
Co-supervisor	Cerebrospinal Fluid Proteomics of Multiple Sclerosis Patients